Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
---|---|---|---|---|---|---|
SC 13G/A | 2024-02-13 | Lind Global Fund II LP | Panbela Therapeutics, Inc. | 0 | - | EDGAR |
SC 13G/A | 2023-02-14 | Cullen Michael T. | Panbela Therapeutics, Inc. | 35,053 | 3.3% | EDGAR |
SC 13G | 2023-01-30 | Lind Global Fund II LP | Panbela Therapeutics, Inc. | 590,000 | - | EDGAR |
SC 13G/A | 2022-02-14 | Cullen Michael T. | Panbela Therapeutics, Inc. | 873,318 | 6.3% | EDGAR |
SC 13G/A | 2021-02-16 | Schemel Donald Robert | Panbela Therapeutics, Inc. | 450,624 | 4.6% | EDGAR |
SC 13G/A | 2021-02-16 | Cullen Michael T. | Panbela Therapeutics, Inc. | 827,271 | 8.2% | EDGAR |
SC 13G | 2020-09-08 | ARMISTICE CAPITAL, LLC | Sun BioPharma, Inc. | 497,029 | 5.0% | EDGAR |
SC 13G/A | 2020-02-14 | Cullen Michael T. | Sun BioPharma, Inc. | 746,571 | 11.3% | EDGAR |
SC 13G/A | 2020-02-14 | Schemel Donald Robert | Sun BioPharma, Inc. | 408,049 | 6.2% | EDGAR |
SC 13D/A | 2019-08-28 | GILBERTSON RYAN RANDALL | Sun BioPharma, Inc. | 212,127 | 3.7% | EDGAR |
SC 13G/A | 2019-08-28 | Ryan R. Gilbertson 2012 Irrevocable Trust | Sun BioPharma, Inc. | 575,109 | 10.1% | EDGAR |
SC 13G/A | 2019-02-14 | Herron Paul M. | Sun BioPharma, Inc. | 236,138 | 4.6% | EDGAR |
SC 13G/A | 2019-02-14 | Schemel Donald Robert | Sun BioPharma, Inc. | 404,649 | 7.9% | EDGAR |
SC 13G/A | 2019-02-14 | Cullen Michael T. | Sun BioPharma, Inc. | 589,076 | 11.1% | EDGAR |
SC 13G/A | 2019-02-14 | POLINSKY DOUGLAS MICHAEL | Sun BioPharma, Inc. | 254,105 | 4.9% | EDGAR |
SC 13D/A | 2019-01-24 | GILBERTSON RYAN RANDALL | Sun BioPharma, Inc. | 555,538 | 11.0% | EDGAR |
SC 13G | 2019-01-24 | Ryan R. Gilbertson 2012 Irrevocable Trust | Sun BioPharma, Inc. | 299,247 | 5.8% | EDGAR |
SC 13G/A | 2018-02-14 | POLINSKY DOUGLAS MICHAEL | Sun BioPharma, Inc. | 198,957 | 5.2% | EDGAR |
SC 13G/A | 2018-02-14 | Herron Paul M. | Sun BioPharma, Inc. | 243,751 | 6.0% | EDGAR |
SC 13D/A | 2017-04-14 | GILBERTSON RYAN RANDALL | Sun BioPharma, Inc. | 6,148,528 | 16.4% | EDGAR |